Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2008 Jan-Feb;12(1):187-8.
doi: 10.1111/j.1582-4934.2008.00248.x. Epub 2008 Jan 19.

Will magnetic resonance imaging (MRI)-based contrast agents for molecular receptor imaging make their way into the clinic?

Kristine Glunde  1 , Zaver M Bhujwalla
Affiliations
Editorial

Will magnetic resonance imaging (MRI)-based contrast agents for molecular receptor imaging make their way into the clinic?

Kristine Glunde et al. J Cell Mol Med. 2008 Jan-Feb.
No abstract available

PubMed Disclaimer

Comment on

  • In vivo detection of c-Met expression in a rat C6 glioma model.
    Towner RA, Smith N, Doblas S, Tesiram Y, Garteiser P, Saunders D, Cranford R, Silasi-Mansat R, Herlea O, Ivanciu L, Wu D, Lupu F. Towner RA, et al. J Cell Mol Med. 2008 Jan-Feb;12(1):174-86. doi: 10.1111/j.1582-4934.2008.00220.x. Epub 2007 Jan 9. J Cell Mol Med. 2008. PMID: 18194445 Free PMC article.

Similar articles

See all similar articles

Cited by

References

    1. Towner RA, Smith N, Doblas S, Tesiram Y, Garteiser P, Saunders D, Cranford R, Silasi-Mansat R, Herlea O, Ivanciu L, Wu D, Lupu F. In vivo detection of c-Met expression in a rat C6 glioma model. J Cell Mol Med. 2008;12:174–1. - PMC - PubMed
    1. Weiner RE, Thakur ML. Radiolabeled peptides in oncology: role in diagnosis and treatment. BioDrugs. 2005;19:145–63. - PubMed
    1. Theuer CP, Leigh BR, Multani PS, Allen RS, Liang BC. Radioimmunotherapy of non-Hodgkin's lymphoma: clinical development of the Zevalin regimen. Biotechnol Annu Rev. 2004;10:265–95. - PubMed
    1. Yao D, Trabulsi EJ, Kostakoglu L, Vallabhajosula S, Joyce MA, Nanus DM, Milowsky M, Liu H, Goldsmith SJ. The utility of monoclonal antibodies in the imaging of prostate cancer. Semin Urol Oncol. 2002;20:211–8. - PubMed
    1. Artemov D, Mori N, Ravi R, Bhujwalla ZM. Magnetic resonance molecular imaging of the HER-2/neu receptor. Cancer Res. 2003;63:2723–7. - PubMed